Abbott Laboratories buy Barclays PLC
Start price
26.01.24
/
50%
€103.14
Target price
26.01.25
€129.82
Performance (%)
1.04%
Price
14:16
€103.70
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 1.04%. Dividends of €0.52 are taken into consideration when calculating the performance. This prediction currently runs until 26.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 2.689% | 2.689% |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Barclays PLC from $133.00 to $141.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Barclays_PLC for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.82
22.04.24
22.04.24
€131.54
22.04.25
22.04.25
2.36%
14:16
14:16